These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3893080)

  • 1. Isosorbide dinitrate and exercise performance in patients with congestive heart failure.
    Franciosa JA
    Am Heart J; 1985 Jul; 110(1 Pt 2):245-50. PubMed ID: 3893080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure.
    Franciosa JA; Cohn JN
    Am J Cardiol; 1979 May; 43(5):1009-14. PubMed ID: 433762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of isosorbide dinitrate on submaximal exercise capacity of patients with chronic left ventricular failure.
    Wilson JR; Ferraro N
    Chest; 1982 Dec; 82(6):701-4. PubMed ID: 7140397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the hemodynamic responses to molsidomine and isosorbide dinitrate in congestive heart failure.
    Unger P; Vachiery JL; de Cannière D; Staroukine M; Berkenboom G
    Am Heart J; 1994 Sep; 128(3):557-63. PubMed ID: 8074020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.
    Leier CV; Huss P; Magorien RD; Unverferth DV
    Circulation; 1983 Apr; 67(4):817-22. PubMed ID: 6337742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic isosorbide dinitrate therapy in congestive heart failure: demonstration of improved exercise capacity and differing arterial and venous tolerance during chronic administration.
    Leier CV; Huss P; Magorien RD; Unverferth DV
    Z Kardiol; 1983; 72 Suppl 3():173-7. PubMed ID: 6666218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of swallowed isosorbide dinitrate on blood pressure, heart rate and exercise capacity in patients with coronary artery disease.
    Glancy DL; Richter MA; Ellis EV; Johnson W
    Am J Med; 1977 Jan; 62(1):39-46. PubMed ID: 319662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure.
    Franciosa JA; Goldsmith SR; Cohn JN
    Am J Med; 1980 Oct; 69(4):559-66. PubMed ID: 7424945
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulatory improvement after hydralazine or isosorbide dinitrate administration in patients with heart failure. Effect on metabolic responses to submaximal exercise.
    Wilson JR; Ferraro N
    Am J Med; 1981 Oct; 71(4):627-33. PubMed ID: 7282752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained hemodynamic and antianginal effects of high dose oral isosorbide dinitrate.
    Aronow S
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2483-6. PubMed ID: 7422537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and circulatory effects of isosorbide dinitrate. Comparison with nitroglycerin.
    Goldstein RE; Rosing DR; Redwood DR; Beiser GD; Epstein SE
    Circulation; 1971 May; 43(5):629-40. PubMed ID: 4996159
    [No Abstract]   [Full Text] [Related]  

  • 12. Immediate effects of hydralazine-isosorbide dinitrate combination on exercise capacity and exercise hemodynamics in patients with left ventricular failure.
    Franciosa JA; Cohn JN
    Circulation; 1979 Jun; 59(6):1085-91. PubMed ID: 436200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of vasodilators and long-term response in heart failure.
    Franciosa JA; Dunkman WB; Leddy CL
    J Am Coll Cardiol; 1984 Jun; 3(6):1521-30. PubMed ID: 6325522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris.
    Markis JE; Gorlin R; Mills RM; Williams RA; Schweitzer P; Ransil BJ
    Am J Cardiol; 1979 Feb; 43(2):265-71. PubMed ID: 367136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new oral slow release form of isosorbide dinitrate. Effect on the hemodynamics and exercise capacity of patients with angina.
    Di Bianco R; Ronan JA; Donohue DJ; Lindgren KM
    Chest; 1983 Dec; 84(6):707-13. PubMed ID: 6641305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captopril.
    Mehra A; Ostrzega E; Shotan A; Johnson JV; Elkayam U
    Am J Cardiol; 1992 Nov; 70(15):1310-4. PubMed ID: 1442583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrate tolerance.
    Leier CV
    Am Heart J; 1985 Jul; 110(1 Pt 2):224-32. PubMed ID: 3925742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of isosorbide dinitrate and hydralazine on regional metabolic responses to arm exercise in patients with heart failure.
    Wilson JR; Untereker W; Hirshfeld J
    Am J Cardiol; 1981 Nov; 48(5):934-8. PubMed ID: 7304441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrates in heart failure. Pathophysiological mechanisms and therapeutic applications.
    Timmis AD; Richardson PJ
    Scand J Clin Lab Invest Suppl; 1984; 173():59-64. PubMed ID: 6442003
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of propranolol and isosorbide dinitrate on exercise performance and adrenergic acitivity in patients with angina pectoris.
    Battock DJ; Alvarez H; Chidsey CA
    Circulation; 1969 Feb; 39(2):157-69. PubMed ID: 4884575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.